Activation of Lipid Mediator Formation Due to Lipoprotein Apheresis

Lipoprotein apheresis reliably reduces low-density lipoprotein (LDL) cholesterol in patients with atherosclerotic disease and therapy-refractory hypercholesterolemia or elevated lipoprotein (a) (Lp(a)). Besides lowering lipoproteins and triglycerides, apheresis also decreases levels of essential ome...

Descripción completa

Detalles Bibliográficos
Autores principales: Weylandt, Karsten-H., Schmöcker, Christoph, Ostermann, Annika I., Kutzner, Laura, Willenberg, Ina, Kiesler, Stefanie, Steinhagen-Thiessen, Elisabeth, Schebb, Nils Helge, Kassner, Ursula
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6412478/
https://www.ncbi.nlm.nih.gov/pubmed/30744123
http://dx.doi.org/10.3390/nu11020363

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6412478/
https://www.ncbi.nlm.nih.gov/pubmed/30744123
http://dx.doi.org/10.3390/nu11020363

Ejemplares similares